Canada Biotechnology & Medical Research

NervGen Pharma Corp (NGEN)

Track

NervGen Pharma Corp has seen significant insider buying activity recently, highlighted by a $2 million purchase from director Adam Rogers in late May 2026. Over the past 90 days, two insiders have acquired shares totaling approximately $2.01 million. This follows a period earlier in the year characterized by multiple share sales by director Krista McKerracher.
Ticker: NGEN Exchange: CVE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for NervGen Pharma Corp. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 28 Jul 2026
Value US$2,288,583.63 | Price 146.99 | Shares 86,552
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-05 2026-07-28 B Purchase
Ruffolo, John

Director of Issuer

Non-Executive Director
86,552
146.99
US$2,288,584 		86,552 146.99 US$2,288,584
2026-06-01 2026-05-27 B Purchase
Ruffolo, John

Director of Issuer

Non-Executive Director
40,487
447.42
CA$3,482,214 		40,487 447.42 CA$3,482,214
2026-06-01 2026-05-27 B Purchase
Ruffolo, John

Director of Issuer

Non-Executive Director
67,158 -28.2%
329.57
US$2,437,589 		67,158 -28.2% 329.57 US$2,437,589
2026-06-03 2026-05-26 B Purchase
Rogers, Adam

Director of Issuer, Director or Senior Officer of 10% Security Holder

Non-Executive Director
800,000 +8.0%
2.50
US$2,000,000 		800,000 +8.0% 2.50 US$2,000,000
2026-05-04 2026-04-29 B Purchase
2.3
Punnett, Harold

10% Security Holder of Issuer, Director of Issuer

Non-Executive Director Large shareholder
4,250 +0.4%
3.74
US$15,912 		4,250 +0.4% 3.74 US$15,912
2026-04-08 2026-04-08 S Sale
3.1
McKerracher, Krista

Director of Issuer

Non-Executive Director
10,000 -26.5%
4.19
US$41,914 		10,000 -26.5% 4.19 US$41,914
2026-04-08 2026-04-02 S Sale
3.1
McKerracher, Krista

Director of Issuer

Non-Executive Director
5,000 -11.7%
4.23
US$21,150 		5,000 -11.7% 4.23 US$21,150
2026-03-13 2026-03-09 S Sale
3.1
McKerracher, Krista

Director of Issuer

Non-Executive Director
5,000 -10.5%
3.98
US$19,924 		5,000 -10.5% 3.98 US$19,924
2026-03-02 2026-03-02 S Sale
3.1
McKerracher, Krista

Director of Issuer

Non-Executive Director
10,000 -17.3%
3.85
US$38,517 		10,000 -17.3% 3.85 US$38,517
2026-03-02 2026-02-26 S Sale
3.1
McKerracher, Krista

Director of Issuer

Non-Executive Director
5,000 -8.0%
4.10
US$20,514 		5,000 -8.0% 4.10 US$20,514
2026-03-02 2026-02-26 S Sale
3.1
McKerracher, Krista

Director of Issuer

Non-Executive Director
5,000 -7.4%
4.13
US$20,639 		5,000 -7.4% 4.13 US$20,639
2026-02-23 2026-02-20 S Sale
3.1
McKerracher, Krista

Director of Issuer

Non-Executive Director
9,980 -12.8%
4.30
US$42,914 		9,980 -12.8% 4.30 US$42,914
2026-02-23 2026-02-19 S Sale
3.1
McKerracher, Krista

Director of Issuer

Non-Executive Director
20 -0.0%
4.30
US$86 		20 -0.0% 4.30 US$86
2026-02-23 2026-02-19 S Sale
3.1
McKerracher, Krista

Director of Issuer

Non-Executive Director
10,000 -11.4%
4.18
US$41,773 		10,000 -11.4% 4.18 US$41,773
2026-02-23 2026-02-18 S Sale
3.1
McKerracher, Krista

Director of Issuer

Non-Executive Director
10,000 -10.2%
4.13
CA$41,312 		10,000 -10.2% 4.13 CA$41,312
2026-02-16 2026-02-12 S Sale
3.1
McKerracher, Krista

Director of Issuer

Non-Executive Director
10,000 -9.3%
4.00
US$39,958 		10,000 -9.3% 4.00 US$39,958
2025-11-20 2025-11-19 B Purchase
3.1
Bayley, Brian Eric

Director of Issuer

Non-Executive Director
250,000 +79.4%
2.10
US$525,000 		250,000 +79.4% 2.10 US$525,000
2025-11-19 2025-11-19 B Purchase
Rogers, Adam

Director of Issuer, Director or Senior Officer of 10% Security Holder

Non-Executive Director
857,143
2.10
US$1,800,000 		857,143 2.10 US$1,800,000
2025-11-19 2025-11-19 B Purchase
Rogers, Adam

Director of Issuer, Director or Senior Officer of 10% Security Holder

Non-Executive Director
952,381 +33.1%
2.10
US$2,000,000 		952,381 +33.1% 2.10 US$2,000,000
2024-03-29 2024-03-28 B Purchase
2.8
Radvak, William Joseph

Director of Issuer

Non-Executive Director
20,000 +1.4%
2.35
CA$47,000 		20,000 +1.4% 2.35 CA$47,000
Explore more

More insider trading research around NervGen Pharma Corp

More insider trades in Canada
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America